Date:7/23/2009

213 99,053 77,746 INCOME FROM OPERATIONS 29,173 28,180 116,958 107,743 NON-OPERATING INCOME (EXPENSE) Interest income 149 759 1,957 4,263 Interest expense (5) (79) (250) (371) Other, net 281 (39) (1,684) 33 Total non-operating income (expense) 425 641 23 3,925 INCOME BEFORE INCOME TAXES 29,598 28,821 116,981 111,668 PROVISION FOR INCOME TAXES 10,166 10,547 40,798 40,214 NET INCOME $19,432 $18,274 $76,183 $71,454 Earnings per share: Per common share - basic $0.28 $0.26 $1.08 $1.02 Per common share - diluted $0.27 $0.26 $1.07 $1.00 Weighted average shares outstanding: Basic 70,447 70,090 70,382 69,867 Diluted 71,055 71,119 71,168 71,109

                                  IMMUCOR, INC.
               SELECTED CONDENSED CONSOLIDATED BALANCE SHEET ITEMS
                            (Unaudited, in thousands)
                                          May 31,           May 31,
                                           2009              2008

    Cash                                 $136,461          $175,056
    Accounts receivable - trade            57,017            52,720
    Inventory                              38,256            32,228
    Total current assets                  244,850           271,575
    Property and equipment - net           43,461            36,426
    Total assets                          451,340           364,950

    Accounts payable                        9,344             7,546
    Deferred revenue, current
     portion                     
'/>"/>
SOURCE  Immucor, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 
Related medicine news :

1. Immucor Appoints Chief Operating Officer
2. Immucor Submits 10-Day Response to FDA; Establishes Product Surveillance and Improvement Department
3. Immucor to Announce Fiscal Fourth Quarter Financial Results on Thursday, July 23, 2009
4. Immucor Announces Fiscal Year 2010 Guidance
5. Immucor to Announce Fiscal 2010 Guidance on Monday, June 1, 2009
6. Immucor to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
7. Immucor Receives Subpoena From Department of Justice
8. Immucor Announces Fiscal Third Quarter Results
9. Immucor Announces New Vice President, Operations
10. Immucor Announces Fiscal Second Quarter Results; Raises Fiscal 2009 EPS Guidance
11. Immucor Closes BioArray Acquisition